Three clinical trial platforms working together to test the effects of anticoagulants in people with COVID-19 have paused enrolment of critically ill hospitalised patients.
Perch News App - Company Name
Three clinical trial platforms working together to test the effects of anticoagulants in people with COVID-19 have paused enrolment of critically ill hospitalised patients.
The past year has been challenging for all of us in the NHS.
When looking at the impact of the pandemic on the field of cardiovascular disease (CVD), reduced screening opportunities and cancelled clinics and procedures have caused widespread disruption.
Draft NICE guidance on the management of atrial fibrillation has come under criticism for its recommendation around the use of apixaban or dabigatran as first choice options for anticoagulation.
A COVID-19 vaccination available before the close of 2020 has brought a glimmer of light in an exceptionally challenging and painful year of the COVID-19 pandemic.
"ON DEATH’S DOOR I was hours from death when a dry cough turned out to be deadly clots caused by the Pill"
Lara N. Roberts, Kate Bramham, Claire C. Sharpe and Roopen Arya, June 2020
Martin B. Whyte, Philip A. Kelly, Elisa Gonzalez, Roopen Arya, Lara N. Roberts, June 2020
I am a 54-year-old female, working as a nurse in the NHS and diagnosed with Antiphospholipid Syndrome in 2015 following an admission to hospital in May 2014 with unprovoked bilateral pulmonary emboli.